Trial Profile
Smith-Lemli-Opitz Syndrome: A Pilot Study of Cholic Acid Supplementation
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 16 Jan 2024
Price :
$35
*
At a glance
- Drugs Cholic acid (Primary)
- Indications Smith-Lemli-Opitz syndrome
- Focus Therapeutic Use
- 21 Nov 2023 Status changed from active, no longer recruiting to completed.
- 07 Nov 2022 Planned End Date changed from 30 Sep 2022 to 30 Sep 2023.
- 01 May 2022 Planned End Date changed from 30 Nov 2021 to 30 Sep 2022.